← 產業報告目錄

Fragment-Based Drug Discovery Market Size, Share & Trends Analysis Report By Technique (X-ray Crystallography, Nuclear Magnetic Resonance, Surface Plasmon Resonance. and Other Screening Techniques), By Service, By End Users, Region And Segment Forecasts, 2023-2031.

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-20頁數 180報告編號 INSIGHTACE-e30927fb45

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

Industry analysis indicates the Fragment-Based Drug Discovery Market globally will accelerate at a 11.0% CAGR during 2023–2031. Fragment-Based Drug Discovery covers reshaping how healthcare entities approach this space. Growth is underpinned by a convergence of factors: rising awareness among end users, continuous product innovation, and the mounting emphasis on efficiency and sustainability within the healthcare sector. From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities. From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector. Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing. Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Fragment-based Drug Discovery Market Snapshot Chapter 4. Global Fragment-based Drug Discovery Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Industry Analysis – Porter's Five Forces Analysis 4.6. Competitive Landscape & Market Share Analysis 4.7. Technology Advancement in Fragment-based Drug Discovery Market 4.8. Key Trends in the Market Chapter 5. Market Segmentation 1: Type of Technique Estimates & Trend Analysis 5.1. Type of Technique & Market Share, 2020 & 2028 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Type of Technique: 5.2.1. X-ray Crystallography 5.2.2. Nuclear Magnetic Resonance 5.2.3. Surface Plasmon Resonance 5.2.4. Other Screening Techniques Chapter 6. Market Segmentation 1: Type of Service Estimates & Trend Analysis 6.1. Type of Service & Market Share, 2020 & 2028 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Type of Service: 6.2.1. Library Screening 6.2.2. Fragment Screening 6.2.3. Fragment Optimization Chapter 7. Fragment-based Drug Discovery Market Segmentation 2: End-Users Estimates & Trend Analysis 7.1. End-Users Analysis & Market Share, 2020 & 2028 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following End-Users: 7.2.1. Industry Players 7.2.2. Non-industry Players Chapter 8. Fragment-based Drug Discovery Market Segmentation 3: Regional Estimates & Trend Analysis 8.1. North America 8.1.1. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by Type of Technique, 2020-2028 8.1.2. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by Type of Service, 2020-2028 8.1.3. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by End-Users, 2020-2028 8.1.4. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by country, 2020-2028 8.1.4.1. U.S. 8.1.4.2. Canada 8.2. Europe 8.2.1. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, 2020-2028 8.2.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028 8.2.3. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by End-Users, 2020-2028 8.2.4. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by country, 2020-2028 8.2.4.1. Germany 8.2.4.2. Poland 8.2.4.3. France 8.2.4.4. Italy 8.2.4.5. Spain 8.2.4.6. UK 8.2.4.7. Rest of Europe 8.3. Asia Pacific 8.3.1. Asia Pacific Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, 2020-2028 8.3.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028 8.3.3. Asia Pacific Fragment-based Drug Discovery Market revenue (US$ Million) by End-Users, 2020-2028 8.3.4. Asia Pacific Fragment-based Drug Discovery Market revenue (US$ Million) by country, 2020-2028 8.3.4.1. China 8.3.4.2. India 8.3.4.3. Japan 8.3.4.4. Australia 8.3.4.5. Rest of Asia Pacific 8.4. Latin America 8.4.1. Latin America Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, (US$ Million) 8.4.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028 8.4.3. Latin America Fragment-based Drug Discovery Market revenue (US$ Million) by End-Users, (US$ Million) 8.4.4. Latin America Fragment-based Drug Discovery Market revenue (US$ Million) by country, (US$ Million) 2020-2028 8.4.4.1. Brazil 8.4.4.2. Rest of Latin America 8.5. MEA 8.5.1. MEA revenue Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, (US$ Million) 2020-2028 8.5.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028 8.5.3. MEA revenue Fragment-based Drug Discovery Market revenue (US$ Million) by country, (US$ Million) 2020-2028 8.5.3.1. South Africa 8.5.3.2. Rest of MEA Chapter 9. Competitive Landscape 9.1. Major Mergers and Acquisitions/Strategic Alliances 9.2. Company Profiles 9.2.1. 2bind 9.2.2. Charles River Laboratories 9.2.3. ChemAxon 9.2.4. ComInnex 9.2.5. ChemDiv 9.2.6. Creative Biolabs 9.2.7. Creative Biostructure 9.2.8. CRELUX 9.2.9. Domainex 9.2.10. Evotec 9.2.11. Red Glead Discovery 9.2.12. SARomics Biostructures 9.2.13. Shanghai ChemPartner 9.2.14. Sygnature Discovery 9.2.15. Vernalis 9.2.16. Other Prominent Player

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們